Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Ozempic is available through mail-order pharmacies
Survodutide (BI 456906) is a novel subcutaneous GCGR/GLP-1R dual agonist in development for the treatment of people with type 2 diabetes, obesity and non-alcoholic steatohepatitis (NASH)
Contact your healthcare provider immediately if you experience severe side effects
When in doubt, ask your physician how much water you should be drinking daily, as the recommended amount depends on your current body weight, activity level and any underlying conditions (beyond taking Ozempic) that may increase your risk of dehydration
Some users feel the effects of a single drink much sooner
In a 2026 survey of people using injectable GLP-1 drugs conducted by health-tech company Evidation Health, 15% of respondents reported microdosing
.jpg)